Robotic Endoscopy Devices Market
Report ID: SQMIG35A3759
Report ID: SQMIG35A3759
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3759 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
184
|Figures:
79
Global Robotic Endoscopy Devices Market size was valued at USD 2.4 Billion in 2024 and is poised to grow from USD 2.62 Billion in 2025 to USD 5.26 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).
Acting as a research analyst, I identify the primary driver of the robotic endoscopy devices market as the clinical imperative for greater precision in minimally invasive diagnostics and therapies. This market includes robotic platforms, steerable endoscopes, advanced imaging attachments and software that enhance visualization and manipulation during endoscopic procedures, and it matters because better accuracy lowers complication rates, shortens hospital stays and enables interventions that were impractical. Over time the sector progressed from flexible video endoscopes toward integrated robotic systems enabled by miniaturized actuators, enhanced imaging and artificial intelligence, and products such as Monarch and Ion clearly illustrate this evolution.
Building on that evolution, a key factor propelling global market growth is the convergence of unmet clinical needs with enabling technologies, which creates opportunities across settings. As demand for early detection of gastrointestinal and pulmonary lesions rises, clinicians adopt robotic platforms because they increase reach and yield, as seen when robotic bronchoscopy improves peripheral lung nodule biopsy success. Payers respond to outcome improvements with reimbursement, which motivates hospitals to invest in systems that shorten stay and lower costs. Meanwhile software advances such as artificial intelligence and remote operation expand use cases into screening and telerobotics, unlocking markets and clinical partnerships.
How is AI enhancing diagnostic accuracy in the robotic endoscopy devices market?
AI is improving diagnostic accuracy in robotic endoscopy by marrying real time image analysis with precision device control. Key aspects include automated polyp detection, lesion characterization, steady camera positioning and fusion of visual and sensor data that together reduce operator variability. In the current market these capabilities are moving from research into commercial systems where AI aids decision making, shortens learning curves and makes findings more reproducible. Examples of this trend include commercial computer aided detection packages that enhance live visualization and support clinical workflows, increasing clinician confidence and accelerating adoption.
Moon Surgical July 2025, received FDA clearance for Maestro connectivity and a Predetermined Change Control Plan for its AI powered ScoPilot which enables iterative AI updates and steadier visualization. This development lets the robotic platform continuously improve image quality and AI decision support, boosting diagnostic reliability and operational efficiency.
Market snapshot - (2026-2033)
Global Market Size
USD 2.4 Billion
Largest Segment
Robotic Laparoscopy Systems
Fastest Growth
Robotic Bronchoscopy Systems
Growth Rate
9.1% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global robotic endoscopy devices market is segmented by by product type, by component, by application, by procedure type, by end user, by technology and region. Based on by product type, the market is segmented into Robotic Flexible Endoscopy Systems, Robotic Capsule Endoscopy Systems, Robotic Bronchoscopy Systems, Robotic Laparoscopy Systems, Robotic Colonoscopy Systems, Robotic Catheter Endoscopy Systems and Others. Based on by component, the market is segmented into Robotic Endoscopes, Robotic Control Systems, Visualization Systems, Navigation & Imaging Software, Accessories & Consumables and Others. Based on by application, the market is segmented into Gastrointestinal Endoscopy, Pulmonology Endoscopy, Urology Endoscopy, Gynecology Endoscopy, ENT Endoscopy, Oncology Procedures and Others. Based on by procedure type, the market is segmented into Diagnostic Procedures and Therapeutic Procedures. Based on by end user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Academic & Research Institutes and Others. Based on by technology, the market is segmented into AI-assisted Robotic Endoscopy, Magnetically Controlled Robotic Endoscopy, Autonomous Navigation Robotic Endoscopy and Teleoperated Robotic Endoscopy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Robotic Flexible Endoscopy Systems segment dominates because these platforms combine therapeutic capability with familiar procedural workflows, enabling broad adoption across clinicians. Their versatility in supporting both diagnostic and interventional procedures, integration with advanced visualization and control modules, and strong vendor investment in training and service ecosystems drive institutional procurement. Clinicians prefer platforms that reduce procedure time variability and accommodate existing operating room setups, creating stable demand and consolidating market leadership.
However, Robotic Capsule Endoscopy Systems are emerging as the most rapidly expanding area due to patient preference for noninvasive screening, improved battery and imaging technology, and AI enabled lesion detection that streamlines interpretation. Their suitability for outpatient and ambulatory workflows and lower procedural burden accelerates adoption, opening opportunities in preventative care and remote diagnostics.
AI assisted Robotic Endoscopy segment leads because embedded machine learning enhances lesion detection, procedural guidance, and real time decision support, directly improving diagnostic yield and clinician confidence. Integration of AI with robotic control optimizes navigation paths and reduces operator workload, making platforms more attractive to institutions pursuing value based care. Growing clinical validation, vendor partnerships, and workflow integration with electronic records further solidify procurement preference and clinical adoption across specialties.
Conversely, Teleoperated Robotic Endoscopy is witnessing the strongest growth momentum as remote operation extends specialist access without patient travel. Improvements in low latency networks, secure control interfaces, and clinical acceptance of remote procedures encourage adoption by care providers, expanding service models and opening new commercialization pathways for manufacturers and platform operators.
To get detailed segments analysis, Request a Free Sample Report
North America dominates the global robotic endoscopy devices market due to a convergence of advanced clinical infrastructure, concentrated industry leadership, and a receptive reimbursement environment. Major academic medical centers and specialty hospitals act as early adoption sites, generating clinical evidence and training multidisciplinary teams. A dense ecosystem of established manufacturers, startups, and investors accelerates product development and commercialization. Regulatory pathways and established reimbursement mechanisms support device introduction and clinical integration. Collaborative partnerships among clinicians, engineers, and payers foster iterative innovation and real world validation. Patient awareness and demand for minimally invasive diagnostics and interventions further encourage diffusion. The result is a virtuous cycle where clinical adoption, local manufacturing capability, and sustained investment reinforce North America position as the global leader in robotic endoscopy.
Robotic Endoscopy Devices Market in United States is characterized by a concentration of leading medical technology firms, substantial procedure activity at tertiary hospitals, and a robust innovation infrastructure. Academic centers drive clinical research and serve as demonstration sites, while venture finance and strategic partnerships expedite commercialization. Emphasis on physician training and multidisciplinary adoption supports refinement of clinical workflows and iterative device improvements coupled with strong post market evidence generation continuously.
Robotic Endoscopy Devices Market in Canada is shaped by universal healthcare frameworks, regional centers of excellence and research networks. Hospitals emphasize evidence based adoption and integration within care pathways, guided by regulatory oversight and health technology assessment. Partnerships between clinical teams and domestic manufacturers foster adaptation to local practice. Training initiatives and cross provincial knowledge exchange help scale expertise while procurement mechanisms and payer priorities influence diffusion across healthcare institutions.
Europe rapid expansion in robotic endoscopy devices is propelled by a combination of sophisticated clinical networks, supportive reimbursement philosophies in key healthcare systems, and a strong manufacturing and engineering base. Leading hospitals and specialist centers across the region act as centers for clinical validation and generate comparative data that influence national procurement decisions. Collaborative research initiatives and public private partnerships facilitate technology transfer and localized development. Regulatory alignment and health technology assessment processes emphasize clinical value and safety, encouraging adoption where clear benefits are demonstrated. Patient demand for minimally invasive diagnostics, along with cross border clinician training and knowledge exchange, accelerates uptake in major markets and creates a dynamic environment for regional expansion and competitive positioning. Investment in surgical robotics and integration with hospital IT strengthens workflows and enables outcome data capture. Professional societies are creating guidance for defined indications, supporting greater clinician acceptance.
Robotic Endoscopy Devices Market in Germany benefits from high hospital capacity, an advanced medtech manufacturing ecosystem, and established specialist centers that drive clinical adoption. Health insurers and hospital procurement prioritize technologies demonstrating clinical and economic value, while academic hospitals generate comparative evidence. Collaboration between engineers and clinicians supports localized product development. Training programs and professional networks facilitate skills dissemination and reinforce Germany position as a regional hub for endoscopic procedures.
Robotic Endoscopy Devices Market in United Kingdom benefits from a concentrated innovation ecosystem, centralized adoption pathways, and targeted procurement pilots that facilitate deployment in specialist centers. Academic hospitals and innovation hubs collaborate with startups and global firms to validate devices within clinical pathways. Digital health integration and clinician training programs support scalable uptake, while focused funding and pilot initiatives accelerate translation from research to routine practice broadly across the country.
Robotic Endoscopy Devices Market in France is emerging through investments in healthcare innovation, academic hospital networks, and public initiatives. Specialist centers and university hospitals lead clinical evaluation and early adoption, partnering with domestic firms. Health technology assessment frameworks encourage integration based on demonstrated benefit, while clinician training and regional pilot programs support scaling. Ongoing collaboration between research institutes and industry is enabling transition from validation to wider clinical use ultimately.
Asia Pacific is strengthening its position in the robotic endoscopy devices market through a combination of technological capability, targeted policy support, and evolving clinical adoption. Mature industrial bases in key markets enable local manufacturers to adapt precision robotics and miniaturized instrumentation to endoscopic applications, while government incentives and R&D programs fuel commercial development. Hospitals are investing in advanced procedural suites and clinician training to integrate robotics into diagnostic and therapeutic workflows. Cross border partnerships with international device makers accelerate knowledge transfer and market entry. Demographic trends and expanding access to specialty care create demand for minimally invasive solutions, and a focus on cost effective, locally adapted devices helps the region build competitive offerings for both domestic use and export. Regulatory modernization and emerging clinical guidelines further support commercialization and wider clinical acceptance across the region.
Robotic Endoscopy Devices Market in Japan is advanced by a deep industrial expertise in precision robotics, established medical device manufacturers, and a clinical community receptive to technology driven solutions. Hospitals and specialty centers emphasize procedural refinement and outcome measurement, facilitating device validation. Government support for healthcare innovation and structured training programs help disseminate clinical skills. Local firms leverage electronics and automation strengths to develop devices tailored to domestic practice commercially.
Robotic Endoscopy Devices Market in South Korea is supported by a strong technology ecosystem and tight industry academic collaboration. Agile domestic firms and startups iterate rapidly, integrating advanced imaging and connectivity for clinician workflows. Government programs and export oriented strategies back commercialization and global partnerships. High quality hospital infrastructure and clinician engagement enable pilot deployments and refinement of protocols, positioning South Korea as a regional innovator in endoscopic robotics broadly.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Technological Advancements In Robotics
Growing Emphasis On Early Diagnosis
High Acquisition And Maintenance Costs
Regulatory Approval and Reimbursement Challenges
Request Free Customization of this report to help us to meet your business objectives.
Competitive landscape is driven by strategic OEM partnerships, regulatory milestones and targeted M&A; incumbent OEMs secure distribution deals to access novel robotic platforms, for example Olympus’ global distribution agreement with EndoRobotics. Large acquirers have consolidated capabilities via deals such as Johnson & Johnson’s acquisition of Auris Health in 2019, and clinical validation plus interoperability commitments are primary drivers shaping competition for hospital procurement.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the key driver is the clinical imperative for greater precision in minimally invasive diagnostics and therapies, which is accelerating adoption of integrated robotic platforms. The second driver is AI enabled procedural precision that improves lesion detection and navigation. The primary restraint is high acquisition and maintenance costs that limit uptake beyond well funded centers. The dominating region is North America driven by advanced clinical infrastructure and supportive reimbursement. The dominating segment is Robotic Flexible Endoscopy Systems because they combine therapeutic capability with familiar workflows, driving hospital procurement and broader clinical integration. These dynamics underpin a projected near term market expansion as hospitals seek to improve diagnostic yield and procedural efficiency.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 2.4 Billion |
| Market size value in 2033 | USD 5.26 Billion |
| Growth Rate | 9.1% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Robotic Endoscopy Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Robotic Endoscopy Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Robotic Endoscopy Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Robotic Endoscopy Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Robotic Endoscopy Devices Market size was valued at USD 2.4 Billion in 2024 and is poised to grow from USD 2.62 Billion in 2025 to USD 5.26 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).
Competitive landscape is driven by strategic OEM partnerships, regulatory milestones and targeted M&A; incumbent OEMs secure distribution deals to access novel robotic platforms, for example Olympus’ global distribution agreement with EndoRobotics. Large acquirers have consolidated capabilities via deals such as Johnson & Johnson’s acquisition of Auris Health in 2019, and clinical validation plus interoperability commitments are primary drivers shaping competition for hospital procurement. 'Intuitive Surgical', 'Medtronic', 'Olympus Corporation', 'Johnson & Johnson', 'Stryker', 'FUJIFILM Holdings', 'Karl Storz', 'EndoMaster', 'Virtuoso Surgical', 'AnX Robotica', 'Robocath', 'Asensus Surgical', 'Hoya Corporation', 'Auris Health', 'CMR Surgical', 'Creo Medical', 'MicroPort Scientific', 'NeoGuide Systems', 'Motus GI', 'STERIS'
Continuous improvements in imaging, articulation, and control systems have enhanced the precision and maneuverability of robotic endoscopy platforms, enabling clinicians to perform complex diagnostic and therapeutic procedures with greater confidence and reduced collateral tissue trauma. These technological advances expand clinical indications, encourage adoption among specialist centers, and foster industry investment in development and training programs. Enhanced functionality and interoperability with existing hospital systems also elevate perceived value, making robotic endoscopy solutions more attractive to healthcare providers seeking to improve outcomes and streamline procedural workflows.
Ai Enabled Procedural Precision: The adoption of machine learning and advanced image processing algorithms within robotic endoscopy systems is enhancing intra procedural decision support, lesion detection, and navigation accuracy. Real time analytics augment operator judgement, reduce inter operator variability, and enable more targeted interventions with smaller instruments. This trend supports expanded clinical indications, facilitates training through automated feedback, and encourages system vendors to prioritize software driven upgrades that improve therapeutic precision and procedural consistency across diverse clinical environments while supporting iterative evidence generation and cross institutional benchmarking efforts.
Why does North America Dominate the Global Robotic Endoscopy Devices Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
